Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

References for PMC Articles for PubMed (Select 15109342)

1.

Improved comorbidity adjustment for predicting mortality in Medicare populations.

Schneeweiss S, Wang PS, Avorn J, Glynn RJ.

Health Serv Res. 2003 Aug;38(4):1103-20.

2.

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB.

N Engl J Med. 2002 Mar 14;346(11):822-9.

3.

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ.

Am J Epidemiol. 2001 Nov 1;154(9):854-64.

4.

Paradoxical relations of drug treatment with mortality in older persons.

Glynn RJ, Knight EL, Levin R, Avorn J.

Epidemiology. 2001 Nov;12(6):682-9.

PMID:
11679797
5.

Causation of bias: the episcope.

Maclure M, Schneeweiss S.

Epidemiology. 2001 Jan;12(1):114-22.

PMID:
11138805
6.

Use of comorbidity scores for control of confounding in studies using administrative databases.

Schneeweiss S, Maclure M.

Int J Epidemiol. 2000 Oct;29(5):891-8. Review.

7.

Strategies for improving comorbidity measures based on Medicare and Medicaid claims data.

Wang PS, Walker A, Tsuang M, Orav EJ, Levin R, Avorn J.

J Clin Epidemiol. 2000 Jun;53(6):571-8.

PMID:
10880775
8.

The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries.

Yuan Z, Cooper GS, Einstadter D, Cebul RD, Rimm AA.

Med Care. 2000 Feb;38(2):231-45.

PMID:
10659696
9.
10.

Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus.

Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J.

J Clin Epidemiol. 1999 Aug;52(8):781-90.

PMID:
10465323
11.

Agreement between physicians' office records and Medicare Part B claims data.

Fowles JB, Lawthers AG, Weiner JP, Garnick DW, Petrie DS, Palmer RH.

Health Care Financ Rev. 1995 Summer;16(4):189-99.

12.

Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly.

Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J.

Am J Epidemiol. 1999 Mar 15;149(6):541-9.

13.

Prediction of coronary heart disease using risk factor categories.

Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB.

Circulation. 1998 May 12;97(18):1837-47.

14.

The treatment of unrelated disorders in patients with chronic medical diseases.

Redelmeier DA, Tan SH, Booth GL.

N Engl J Med. 1998 May 21;338(21):1516-20.

15.

Comorbidity measures for use with administrative data.

Elixhauser A, Steiner C, Harris DR, Coffey RM.

Med Care. 1998 Jan;36(1):8-27.

PMID:
9431328
16.

Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves.

Moons KG, Stijnen T, Michel BC, B├╝ller HR, Van Es GA, Grobbee DE, Habbema JD.

Med Decis Making. 1997 Oct-Dec;17(4):447-54.

PMID:
9343803
17.

Practical considerations on the use of the Charlson comorbidity index with administrative data bases.

D'Hoore W, Bouckaert A, Tilquin C.

J Clin Epidemiol. 1996 Dec;49(12):1429-33.

PMID:
8991959
18.

Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data.

Ghali WA, Hall RE, Rosen AK, Ash AS, Moskowitz MA.

J Clin Epidemiol. 1996 Mar;49(3):273-8.

PMID:
8676173
19.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

Romano PS, Roos LL, Jollis JG.

J Clin Epidemiol. 1993 Oct;46(10):1075-9; discussion 1081-90. No abstract available.

PMID:
8410092
20.

Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.

Anderson GM, Kerluke KJ, Pulcins IR, Hertzman C, Barer ML.

Inquiry. 1993 Summer;30(2):199-207.

PMID:
8314608
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk